Cite
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction
MLA
Slobodan Vukicevic, et al. Bone Morphogenetic Protein 1.3 Inhibition Decreases Scar Formation and Supports Cardiomyocyte Survival after Myocardial Infarction. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....629540f6f75c2ccfaa9a909d1d0e7b0a&authtype=sso&custid=ns315887.
APA
Slobodan Vukicevic, Andrea Colliva, Vera Kufner, Valentina Martinelli, Silvia Moimas, Simone Vodret, Viktorija Rumenovic, Milan Milosevic, Boris Brkljacic, Diana Delic-Brkljacic, Ricardo Correa, Mauro Giacca, Manuel Maglione, Tatjana Bordukalo-Niksic, Ivo Dumic-Cule, & Serena Zacchigna. (2022). Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction.
Chicago
Slobodan Vukicevic, Andrea Colliva, Vera Kufner, Valentina Martinelli, Silvia Moimas, Simone Vodret, Viktorija Rumenovic, et al. 2022. “Bone Morphogenetic Protein 1.3 Inhibition Decreases Scar Formation and Supports Cardiomyocyte Survival after Myocardial Infarction,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....629540f6f75c2ccfaa9a909d1d0e7b0a&authtype=sso&custid=ns315887.